|
Jeff Davis has extensive experience in investment banking and corporate development and financing for development stage life sciences companies. Dr. Davis currently President of SCO Financial Group LLC and President and Financial Principal of SCO Securities LLC SCO's NASD-member broker-dealer. Additionally Mr. Davis has served on many boards of directors for life sciences companies and currently sits on the boards of Virium Pharmaceuticals Inc. and Somanta Pharmaceuticals Inc.
Previously served as a Chief Financial Officer of a publicly traded NASDAQ-NM healthcare technology company. Prior to that was Vice President Corporate Finance at Deutsche Bank AG and Deutsche Morgan Grenfell both in the U.S. and Europe. Also served in senior marketing and product management positions at AT&T Bell Laboratories where he was also a member of the technical staff. Prior to that was involved in marketing and product management at Philips Medical Systems North America. Jeff Davis has an M.B.A. from the Wharton School of Business University of Pennsylvania and a B.S. in Biomedical Engineering from the College of Engineering Boston University. | 